公司资料

UnitedHealth Group 股价、新闻与催化剂

股票代码:
UNH
交易所:
NYSE
行业:
Healthcare Services
所在地:
United States

股票表现

395.62 USD (-1.52%)

收盘价

最后更新: 2026年8月17日

343B USD

市值

股价为何变动

The latest company update was “Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)”. UNH changed 1.52% and closed at $395.62 on Aug 17, 2026, indicating a relatively limited closing-price reaction to this company update.

公司概览

业务概览

UnitedHealth Group is a diversified healthcare company with insurance, care delivery, and services operations through UnitedHealthcare and Optum. The company’s story is driven more by managed-care scale, services growth, and operating execution than by classic biotech catalysts.

所在地与行业分类

Headquartered in the United States and listed on NYSE, UnitedHealth sits in managed care and healthcare services. Its geographic footprint is broad and largely U.S.-centered, with a large national commercial presence.

商业模式特征

The business combines premium revenue, healthcare services, data-enabled operations, and care delivery infrastructure. Investors tend to watch membership trends, medical cost ratios, Optum growth, and regulatory or reimbursement pressure.

生物医药行业定位

UnitedHealth is not a biotech company, but it matters to healthcare investors because it sits at the center of payer and provider economics. Its stock is driven by operational and policy factors rather than drug-development catalysts.

未来催化剂

  • UnitedHealth Group's catalyst setup now looks most tied to CRB-701, CANYON-1, and the rest of its current pipeline. What gives this more shape is “Having reached broad alignment with the FDA, we’re on track to start a registrational study for CRB-701 in second-line HNSCC this summer. That setup makes the next update more important than the headline financials themselves.

近期新闻

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

相似股票

商业成熟度、治疗领域或催化剂模式相近的同行公司。